IBM Rational ClearQuest up to 2002.05.00 Web Client cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.3 | $0-$5k | 0.00 |
Summary
A vulnerability described as problematic has been identified in IBM Rational ClearQuest up to 2002.05.00. Affected by this issue is some unknown functionality of the component Web Client. The manipulation results in cross site scripting. This vulnerability is identified as CVE-2005-2994. The attack can be executed remotely. There is not any exploit available.
Details
A vulnerability, which was classified as critical, was found in IBM Rational ClearQuest up to 2002.05.00 (Business Process Management Software). Affected is an unknown code block of the component Web Client. The manipulation with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-80. The product receives input from an upstream component, but it does not neutralize or incorrectly neutralizes special characters such as "<", ">", and "&" that could be interpreted as web-scripting elements when they are sent to a downstream component that processes web pages. This is going to have an impact on confidentiality, integrity, and availability. CVE summarizes:
Unspecified vulnerability in the web client for IBM Rational ClearQuest 2002.05.00 and 2002.05.20, and 2003.06.00 through 2003.06.15 before SR5, allows remote attackers to execute XML Style Sheets (XSS).
The weakness was released 09/20/2005 (Website). The advisory is available at www-1.ibm.com. This vulnerability is traded as CVE-2005-2994 since 09/20/2005. It is possible to launch the attack remotely. The exploitation doesn't require any form of authentication. Successful exploitation requires user interaction by the victim. The technical details are unknown and an exploit is not available. This vulnerability is assigned to T1059.007 by the MITRE ATT&CK project.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at Secunia (SA16717†). If you want to get best quality of vulnerability data, you may have to visit VulDB.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.3VulDB Meta Temp Score: 6.3
VulDB Base Score: 6.3
VulDB Temp Score: 6.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-80 / CWE-74 / CWE-707
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
09/20/2005 🔍09/20/2005 🔍
09/20/2005 🔍
09/20/2005 🔍
03/11/2015 🔍
07/28/2017 🔍
Sources
Vendor: ibm.comAdvisory: www-1.ibm.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2005-2994 (🔍)
GCVE (CVE): GCVE-0-2005-2994
GCVE (VulDB): GCVE-100-26346
Secunia: 16717 - Rational ClearQuest Cross-Site Scripting Vulnerability, Less Critical
Entry
Created: 03/11/2015 23:39Updated: 07/28/2017 10:33
Changes: 03/11/2015 23:39 (52), 07/28/2017 10:33 (1)
Complete: 🔍
Cache ID: 216::103
If you want to get best quality of vulnerability data, you may have to visit VulDB.
No comments yet. Languages: en.
Please log in to comment.